Joint Filing AgreementJoint Filing Agreement • April 20th, 2021 • Versant Venture Capital V, L.P. • Biological products, (no disgnostic substances)
Contract Type FiledApril 20th, 2021 Company IndustryThe undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Ordinary Shares of VectivBio Holding AG shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Shareholders Agreement regarding VectivBio Holding AG 88 | 99Shareholder Agreement • April 20th, 2021 • Versant Venture Capital V, L.P. • Biological products, (no disgnostic substances)
Contract Type FiledApril 20th, 2021 Company Industry